MedPacto, Inc. (KOSDAQ:235980)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,650.00
-220.00 (-3.75%)
At close: Feb 6, 2026
62.59%
Market Cap193.65B +15.9%
Revenue (ttm)2.47B
Net Income-14.57B
EPS-426.07
Shares Out34.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume350,493
Average Volume542,755
Open5,600.00
Previous Close5,870.00
Day's Range5,500.00 - 5,950.00
52-Week Range2,750.00 - 8,650.00
Beta0.60
RSI39.73
Earnings DateMar 19, 2026

About MedPacto

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 235980
Full Company Profile

Financial Performance

Financial Statements